Lieftink Cor

Division of Molecular Carcinogenesis and the NKI Robotics and Screening Center the Netherlands Cancer Institute

关注

立即认领

关注

立即认领

基本信息

浏览量：46

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 130 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplementary Fig. S2 from A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat Following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma

Alaa Embaby,Sanne C.F.A. Huijberts, Liqin Wang,Rodrigo Leite de Oliveira,Hilde Rosing,Bastiaan Nuijen,Joyce Sanders,Ingrid Hofland,Charlaine van Steenis,Roelof J.C. Kluin,Cor Lieftink, Christopher G. Smith,Christian U. Blank,Johannes V. van Thienen,John B.A.G. Haanen,Neeltje Steeghs,Frans L. Opdam,Jos H. Beijnen,Alwin D.R. Huitema,Rene Bernards,Jan H.M. Schellens,Sofie Wilgenhof

crossref（2024）

引用0浏览0引用

Supplementary Fig. S5 from A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat Following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma

crossref（2024）

引用0浏览0引用

PARG-deficient Tumor Cells Have an Increased Dependence on EXO1/FEN1-mediated DNA Repair

Christina Andronikou,Kamila Burdova,Diego Dibitetto,Cor Lieftink,Elke Malzer,Hendrik J Kuiken,Ewa Gogola,Arnab Ray Chaudhuri,Roderick L Beijersbergen,Hana Hanzlikova,Jos Jonkers,Sven Rottenberg

The EMBO Journal（2024）

引用5浏览0WOS引用

Supplementary Table S3 from A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat Following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma

crossref（2024）

引用0浏览0引用

Supplementary Table S2 from A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat Following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma

crossref（2024）

引用0浏览0引用

Table S6 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy

Matheus Henrique Dias,Anoek Friskes,Siying Wang,Joao M. Fernandes Neto,Frank van Gemert,Soufiane Mourragui,Chrysa Papagianni,Hendrik J. Kuiken,Sara Mainardi,Daniel Alvarez-Villanueva,Cor Lieftink,Ben Morris,Anna Dekker,Emma van Dijk,Lieke H.S. Wilms,Marcelo S. da Silva,Robin A. Jansen,Antonio Mulero-Sánchez,Elke Malzer,August Vidal,Cristina Santos,Ramón Salazar,Rosangela A.M. Wailemann,Thompson E.P. Torres,Giulia De Conti,Jonne A. Raaijmakers,Petur Snaebjornsson,Shengxian Yuan,Wenxin Qin,John S. Kovach,Hugo A. Armelin,Hein te Riele,Alexander van Oudenaarden,Haojie Jin,Roderick L. Beijersbergen,Alberto Villanueva,Rene H. Medema,Rene Bernards

crossref（2024）

引用0浏览0引用

Figure S2 from Paradoxical Activation of Oncogenic Signaling As a Cancer Treatment Strategy

crossref（2024）

引用0浏览0引用

ADARp150 Counteracts Whole Genome Duplication

Frank van Gemert, Alexandra Drakaki, Isabel Morales Lozano,Daniel de Groot, Maud Schoot Uiterkamp,Natalie Proost,Cor Lieftink,Marieke van de Ven,Roderick L. Beijersbergen,Heinz Jacobs,Hein te Riele

Nucleic Acids Research（2024）

引用0浏览0WOS引用

Figure S10 from Paradoxical Activation of Oncogenic Signaling As a Cancer Treatment Strategy

crossref（2024）

引用0浏览0引用

Supplementary Table S1 from A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat Following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma

crossref（2024）

引用0浏览0引用

加载更多

作者统计

#Papers: 130

#Citation: 3896

H-Index: 27

G-Index: 62

Sociability: 6

Diversity: 2

Activity: 86

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn